PeptidePicker
Home/Peptides/Adipotide
Fat LossResearch

Adipotide

Also known as: CKGGRAKDC-GG-D(KLAKLAK)2 · Prohibitin-targeting peptide

An aggressive peptidomimetic that eradicates white fat by destroying the blood supply feeding fat cells. Carries severe renal toxicity risk.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2–4 hours

Typical Dose

Research only

Administration

Subcutaneous injection

Mechanism of Action

Targets prohibitin on fat vasculature endothelium and delivers a pro-apoptotic sequence that collapses blood supply to adipose tissue.

Key Research Areas

fat lossaggressivevascularexperimental

Frequently Asked Questions

What is Adipotide?
An aggressive peptidomimetic that eradicates white fat by destroying the blood supply feeding fat cells. Carries severe renal toxicity risk.
How does Adipotide work?
Targets prohibitin on fat vasculature endothelium and delivers a pro-apoptotic sequence that collapses blood supply to adipose tissue.
What is the recommended dosage for Adipotide?
The typical research dosage is Research only, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Adipotide?
The half-life of Adipotide is approximately ~2–4 hours. This affects dosing frequency and timing in research protocols.
Is Adipotide FDA approved?
Adipotide is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Adipotide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Fat Loss